Biograph

Biograph is a longevity-focused health platform that combines at-home and in-clinic biomarker testing with personalized health guidance, positioning itself for people who want deep insight into how they age. It sells membership-based testing and coaching programs. According to WellRank's latest index, Biograph ranks 14th in the at-home lab testing category with 8% AI answer visibility, and the single AI mention captured in the corpus is positive in tone.

Biograph operates as a longevity health company that pairs comprehensive lab testing with expert-guided interpretation, helping members understand and optimize their biological age and long-term health trajectory. Its business model centers on recurring memberships rather than one-off test purchases, which aligns it with concierge-style health services. Founding details and headquarters are not widely confirmed in public sources.

• Membership-based biomarker testing programs covering a broad panel of longevity-relevant blood markers
• Personalized health reports and expert review of test results
• Ongoing health coaching and protocol recommendations tied to test data
• Biological age and healthspan tracking over time
• Access to curated longevity-focused testing panels comparable to those discussed in resources like recommended blood tests for longevity

Biograph primarily serves health-conscious adults in the United States who are proactively focused on longevity, preventive health, and optimizing their biological age. It appeals to people seeking more than standard annual bloodwork, particularly those interested in tracking biomarkers associated with aging and metabolic health. Geographic focus appears to be the US, though broader availability is not publicly confirmed.

• A 40-something professional who tracks health metrics closely and wants clinician-reviewed biomarker data rather than self-interpreted results.
• A biohacker or longevity enthusiast already familiar with services like InsideTracker or Everlywell who is looking for a more comprehensive membership model.
• An executive or high-performer willing to invest in premium preventive health programs that go beyond what their primary care physician offers.
• Someone who has read widely about longevity biomarkers and wants a structured, ongoing testing plan.

Funding stage, total capital raised, and valuation are not publicly disclosed. The company does not appear to be publicly traded.

Biograph has been gaining organic traction in AI-generated answers about at-home and longevity-focused lab testing, suggesting growing content visibility in this niche. The company's membership model reflects a broader industry shift toward subscription-based preventive health services. No specific product launches or funding announcements are widely confirmed in public sources at this time.

The AI answer corpus indexed by WellRank contains one mention of Biograph, and that mention is positive in tone, with no neutral or cautious mentions recorded. This limited but favorable signal suggests AI engines frame the brand constructively when they do reference it, though the small sample size means sentiment should be interpreted carefully. Broader public review data is not aggregated in widely cited third-party sources at scale.

Biograph uses a membership-based pricing model; specific tier prices and annual costs are not published in widely accessible public sources. Visitors are directed to the memberships page for current offerings. Pricing is not publicly disclosed in a stable, broadly cited format.